These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 29196956)

  • 21. Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice.
    Xu XY; Du Y; Liu X; Ren Y; Dong Y; Xu HY; Shi JS; Jiang D; Xu X; Li L; Xu ZH; Geng Y
    Cell Commun Signal; 2020 Sep; 18(1):151. PubMed ID: 32933544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells.
    Li ZJ; Ou-Yang PH; Han XP
    Cell Signal; 2014 Jan; 26(1):141-8. PubMed ID: 24100264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of TGF-β1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis.
    Li HY; Ju D; Zhang DW; Li H; Kong LM; Guo Y; Li C; Wang XL; Chen ZN; Bian H
    Sci Rep; 2015 Nov; 5():16552. PubMed ID: 26559755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics counteract the expression of hepatic profibrotic genes via the attenuation of TGF-β/SMAD signaling and autophagy in hepatic stellate cells.
    Kanmani P; Kim H
    PLoS One; 2022; 17(1):e0262767. PubMed ID: 35051234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal.
    Lee EH; Park KI; Kim KY; Lee JH; Jang EJ; Ku SK; Kim SC; Suk HY; Park JY; Baek SY; Kim YW
    Phytomedicine; 2019 Sep; 62():152780. PubMed ID: 31121384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
    Xiu AY; Ding Q; Li Z; Zhang CQ
    Drug Des Devel Ther; 2021; 15():3643-3659. PubMed ID: 34456560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ghrelin Attenuates Liver Fibrosis through Regulation of TGF-β1 Expression and Autophagy.
    Mao Y; Zhang S; Yu F; Li H; Guo C; Fan X
    Int J Mol Sci; 2015 Sep; 16(9):21911-30. PubMed ID: 26378522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-β1 and TGF-β2 abundance in liver diseases of mice and men.
    Dropmann A; Dediulia T; Breitkopf-Heinlein K; Korhonen H; Janicot M; Weber SN; Thomas M; Piiper A; Bertran E; Fabregat I; Abshagen K; Hess J; Angel P; Coulouarn C; Dooley S; Meindl-Beinker NM
    Oncotarget; 2016 Apr; 7(15):19499-518. PubMed ID: 26799667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMP-activated protein kinase activator, HL156A reduces thioacetamide-induced liver fibrosis in mice and inhibits the activation of cultured hepatic stellate cells and macrophages.
    Lee HS; Shin HS; Choi J; Bae SJ; Wee HJ; Son T; Seo JH; Park JH; Kim SW; Kim KW
    Int J Oncol; 2016 Oct; 49(4):1407-14. PubMed ID: 27498767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CAT1 silencing inhibits TGF-β1-induced mouse hepatic stellate cell activation in vitro and hepatic fibrosis in vivo.
    Peng F; Tian Y; Ma J; Xu Z; Wang S; Tang M; Lei J; Gong G; Jiang Y
    Cytokine; 2020 Dec; 136():155288. PubMed ID: 32980687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
    Zhao XY; Zeng X; Li XM; Wang TL; Wang BE
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):963-8. PubMed ID: 19413596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Siniruangan Recipe on Proliferation, Apoptosis and Activation of Human Hepatic Stellate Cell Line LX-2.
    Liu J; Zhao G; Ai B; He Y; Mei M; Zou J; Xiao B; Yin Z
    Pharmacology; 2019; 104(5-6):342-351. PubMed ID: 31390636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
    Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease.
    Xie F; Jia L; Lin M; Shi Y; Yin J; Liu Y; Chen D; Meng Q
    J Cell Mol Med; 2015 Jan; 19(1):155-64. PubMed ID: 25256142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of FUT8 inhibits TGF-β1-induced activation of hepatic stellate cells during liver fibrogenesis.
    Kuang M; Wu H; Hu L; Guo X; He D; Liu B; Chen M; Gu J; Gu J; Zeng X; Ruan Y
    Glycoconj J; 2021 Feb; 38(1):77-87. PubMed ID: 33608773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2.
    Guo GH; Tan DM; Zhu PA; Liu F
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):59-64. PubMed ID: 19208517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Praziquantel ameliorates CCl
    Liu J; Kong D; Qiu J; Xie Y; Lu Z; Zhou C; Liu X; Zhang R; Wang Y
    Br J Pharmacol; 2019 Dec; 176(24):4666-4680. PubMed ID: 31412137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
    Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.